NCT03668028View on ClinicalTrials.gov

A Phase I/III Clinical Study of TPX-114 for the Treatment of Full-Thickness Rotator Cuff Tear

PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

September 27, 2021

Study Completion Date

April 28, 2022

Conditions
Rotator Cuff Injuries
Interventions
BIOLOGICAL

TPX-114

Subjects will be treated with autologous fibroblasts (TPX-114) during arthroscopic surgery.

PROCEDURE

Arthroscopic surgery

Subjects undergo conventional arthroscopic surgery for rotator cuff repair.

Trial Locations (2)

13620

Seoul National University Bundang Hospital, Seongnam-si

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Tego Science, Inc.

INDUSTRY

NCT03668028 - A Phase I/III Clinical Study of TPX-114 for the Treatment of Full-Thickness Rotator Cuff Tear | Biotech Hunter | Biotech Hunter